Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Over To You Jerome

Published 07/28/2021, 04:02 AM
Updated 03/05/2019, 07:15 AM

Wait-and-see ahead of FOMC meeting

Asian markets are likely to spend the day in wait-and-see mode with a slight downward bias today, as the street moves into a pre-FOMC holding pattern. Although I am not expecting any change in the statement’s language this time around, the FOMC surprised me last time, so I won’t say never say never. Markets appear to be similarly inclined and guarded against the outside chance that Mr Powell and friends may indicate they are starting to think about starting to talk about the possibility that they may start pondering tapering. September’s meeting remains my favourite for that kick-off, but hey, it’s 2021.

A few winds are blowing against a tapering statement today, not least the Delta variant sweeping the Asia Pacific with an inevitable knock-on to its recovery. You can pencil in parts of the US as well. The bi-partisan US infrastructure negotiations also seem to have hit an impasse and dropped out of the news, never a good sign. Additionally, and equally forgotten, the US federal debt ceiling limit is looming and will we, or will we not, have another government shutdown.

Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT) delivered strong quarterly earnings but got marked down on chip shortages and peak cloud. Alphabet (NASDAQ:GOOGL) blew expectations out of the water and rallied while investors woke up and smelt the coffee with Starbucks (NASDAQ:SBUX), who signalled falling sales in China. We have Facebook (NASDAQ:FB) to come today and Amazon (NASDAQ:AMZN) this week as well, but it is clear that an enormous amount of good news is built into US big-tech prices, and nothing short of an Alphabet level result will stop the profit-takers. Still, any dips in big-tech remain there to be snaffled.

The China regulatory crackdown show continued delivering yesterday, with the Hang Seng enduring another torrid day. I expect today to be a better one as stories are emerging from mainland news journals that more fiscal stimulus is on the way from the central government in Q3. That should sate the wolves for now, but I suspect the repricing of China regulatory risk has some way to run yet. Eventually, the discount in stock prices will balance out the perceived risk for investors, such is the beauty of the market, but I can’t tell you when that will be.

US bond yields continued to sag yesterday and finally dragged the US dollar down with them and showing no pre-FOMC nerves compared to other asset classes. I am beginning t think the bond rally is a giant short squeeze. However, I acknowledge that the persistence of Covid-19 and slowing vaccination rates could temper the recovery exuberance from a US perspective. Interestingly, the IMF upgraded the GDP of developed economies yesterday while downgrading developing ones. That highlights the reality of the K-shaped recovery globally, with the vaccine, haves having, and the have-nots (the rest of us) not having.

Sitting in Jakarta, which like much of ASEAN, is in a world of Covid-19 pain right now, talk of booster shots in the US and Europe against a background of vaccinating apathy does make the heart sink. It means the rest of us will be waiting in the queue for longer while the Northern Hemisphere enjoys summer holidays and an assertion of their individual rights. On a personal level, it is infuriating; on a macro level, it inevitably means that the rollout of tier-one vaccines to the rest of the world will be later and longer, widening the K-shaped recovery. As one learned politician here in Indonesia said (yes, we do have some), “no one is safe until we are all safe.”

Data releases in Asia today have been thin on the ground. The Bank of Japan summary of opinions stated that the BOJ would not tighten monetary policy prematurely. I’m pretty sure that line has been unchanged for the last 20 years. RBA Inflation YoY for Q2 came in slightly higher at 0.80%, with the weighted and trimmed means on expectation. More attention was given to the 4-week extension of movement restrictions in Sydney, which again seems to have been well priced in. We can now assume that any thoughts of tightening by the RBA are off the table for now, and hopefully, the anti-restriction bogans stay at home as well. Come to Jakarta to see your future if you don’t; it’s not pretty.

Malaysia’s Balance of Trade is likely to see the effects of the movement control orders in the data, and the surplus could fall to around MYR 10 billion. Despite the recovery in oil prices, the ringgit remains near recent lows versus the US dollar as its Covid-19 situation and political fragility lurch from worse to worse. Even a spike in oil prices is unlikely to change that narrative for now or the other members of my Asian fragile five. Thailand’s Industrial Production will likely tell a similar story.

The European and US calendars are thin and second-tier today, with Facebook earnings and the FOMC rate decision and statement set to steal the headlines. If all goes to plan, equity markets should move higher on an unchanged FOMC, the US dollar will ease, and US bond yields will continue to grind lower. Over to you, Jerome.

Original Post

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

holle
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.